Safety and Immunogenicity of a Synthetic Nanoparticle-Based, T Cell Priming Peptide Vaccine Against SARS-CoV-2 in Healthy Adults in Switzerland: A Double-Blind, Randomized, Vehicle-Controlled, Phase 1 Study
Lists
Only you see this
BibTeX
@misc{besson2024safety,
author = {Juliette Besson and Maxime Karlen and R Audran and Alix Miauton and Hélène Maby–El Hajjami and Loane Warpelin‐Decrausaz and Loredana Sene and Sylvain Schaufelberger and Vincent Faivre and Mohamed Faouzi and Mary‐Anne Hartley and François Spertini and Blaise Genton},
title = {{Safety and Immunogenicity of a Synthetic Nanoparticle-Based, T Cell Priming Peptide Vaccine Against SARS-CoV-2 in Healthy Adults in Switzerland: A Double-Blind, Randomized, Vehicle-Controlled, Phase 1 Study}},
year = {2024},
doi = {10.2139/ssrn.4867531},
howpublished = {SSRN},
}Loading related content...